Galmed Pharmaceuticals Ltd（GLMD）價格預測GLMDGalmed Pharmaceuticals Ltd

Alphio's GLMD stock price prediction model matches the current Galmed Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.58 (-1.17%). The 1-week path is $4.68 (+1.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Galmed Pharmaceuticals Ltd is not a good buy right now due to its declining stock performance and negative financial indicators. The current price is $3.88, with a year-to-date change of -41.06% and a one-year change of -64.60%. Additionally, the company reported a last earnings EPS of -2.86, indicating ongoing losses. The RSI is at 33.289, suggesting the stock is oversold but may not recover soon given the persistent negative net income figures, such as -4,818,000 USD in Q4 2025. The main risk is the continued negative earnings trend, which has resulted in a forward P/E ratio of 0, indicating no earnings growth is expected in the near future.

Galmed Pharmaceuticals Ltd (GLMD) last closed at $4.63, gaining +21.05%. These facts feed the 1-day and 1-week GLMD price prediction above.